Literature DB >> 28148545

Tumor-Associated Monocytes/Macrophages Impair NK-Cell Function via TGFβ1 in Human Gastric Cancer.

Liu-Sheng Peng1, Jin-Yu Zhang1, Yong-Sheng Teng1, Yong-Liang Zhao2, Ting-Ting Wang1, Fang-Yuan Mao1, Yi-Pin Lv1, Ping Cheng1, Wen-Hua Li1, Na Chen1, Mubing Duan3, Weisan Chen3, Gang Guo1, Quan-Ming Zou4, Yuan Zhuang4.   

Abstract

Natural killer (NK) cells are a major component of the host antitumor immune response in human cancer. However, the nature, functional regulation, and clinical relevance of NK cells in gastric cancer remain largely unknown. In this study, we showed that the percentages of NK cells in tumors were significantly decreased, and low percentages of tumor-infiltrating NK cells were positively correlated with poor survival and disease progression. Although the expression of activating and inhibitory receptors on NK cells was shown to be not different between tumor and nontumor tissues, NK cells in tumors had impaired effector functions, characterized by decreased IFNγ, TNFα, and Ki-67 expression. We found that tumor-infiltrating monocytes/macrophages were physically close to NK cells, and their percentages negatively correlated with IFNγ+ and TNFα+ NK-cell percentages. Ex vivo study showed that isolated tumor-associated monocytes/macrophages could impair NK-cell expression of IFNγ, TNFα, and Ki-67. Blockade of TGFβ1 attenuated such monocytes/macrophages-mediated impairment of NK-cell function. Our data suggest that human NK-cell function was impaired by tumor-associated monocytes/macrophages, and that restoring NK-cell function may be an important therapeutic strategy to prevent tumor immune escape in gastric cancer. Cancer Immunol Res; 5(3); 248-56. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28148545     DOI: 10.1158/2326-6066.CIR-16-0152

Source DB:  PubMed          Journal:  Cancer Immunol Res        ISSN: 2326-6066            Impact factor:   11.151


  64 in total

1.  Intratumoral Immune Response to Gastric Cancer Varies by Molecular and Histologic Subtype.

Authors:  Teresa S Kim; Edaise da Silva; Daniel G Coit; Laura H Tang
Journal:  Am J Surg Pathol       Date:  2019-06       Impact factor: 6.394

2.  Patrolling Monocytes Control NK Cell Expression of Activating and Stimulatory Receptors to Curtail Lung Metastases.

Authors:  Prakash Babu Narasimhan; Tobias Eggert; Yanfang Peipei Zhu; Paola Marcovecchio; Melissa A Meyer; Runpei Wu; Catherine C Hedrick
Journal:  J Immunol       Date:  2019-11-25       Impact factor: 5.422

3.  Expression of PD-L1 in mononuclear cells, multinucleated cells, and foam cells in tenosynovial giant cell tumors.

Authors:  Biqiang Zheng; Lin Yu; Jingying Hu; Huili Xu; Jian Wang; Yingqiang Shi; Xiaoying Luo; Wangjun Yan
Journal:  Int J Clin Exp Pathol       Date:  2019-03-01

Review 4.  Genetic reprogramming for NK cell cancer immunotherapy with CRISPR/Cas9.

Authors:  Lukman O Afolabi; Adeleye O Adeshakin; Musbahu M Sani; Jiacheng Bi; Xiaochun Wan
Journal:  Immunology       Date:  2019-08-14       Impact factor: 7.397

Review 5.  Tumor-Infiltrating Natural Killer Cells.

Authors:  Beatriz Cózar; Marco Greppi; Sabrina Carpentier; Emilie Narni-Mancinelli; Laura Chiossone; Eric Vivier
Journal:  Cancer Discov       Date:  2020-12-04       Impact factor: 39.397

6.  Adaptive immunity profiling associated with histological subtypes and postoperative survival in gastric cancer.

Authors:  Wei Niu; Xiaxia Du; Lianyi Guo; Baohai Liu; Yanyun Wang; Meng Guo; Lili Sun
Journal:  J Gastrointest Oncol       Date:  2021-04

Review 7.  Targeting the tumor microenvironment in cholangiocarcinoma: implications for therapy.

Authors:  Juan Wang; Sumera Ilyas
Journal:  Expert Opin Investig Drugs       Date:  2020-12-28       Impact factor: 6.206

Review 8.  Tumor-infiltrating lymphocytes in the immunotherapy era.

Authors:  Sterre T Paijens; Annegé Vledder; Marco de Bruyn; Hans W Nijman
Journal:  Cell Mol Immunol       Date:  2020-11-02       Impact factor: 11.530

Review 9.  TGF-β links glycolysis and immunosuppression in glioblastoma.

Authors:  Lingli Gong; Li Ji; Daxing Xu; Jingjing Wang; Jian Zou
Journal:  Histol Histopathol       Date:  2021-07-29       Impact factor: 2.303

10.  Gastric Cancer Mesenchymal Stem Cells Inhibit NK Cell Function through mTOR Signalling to Promote Tumour Growth.

Authors:  Shuwei Guo; Chao Huang; Fengfeng Han; Bin Chen; Ying Ding; Yuanyuan Zhao; Zhihong Chen; Shaodi Wen; Mei Wang; Bo Shen; Wei Zhu
Journal:  Stem Cells Int       Date:  2021-06-29       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.